These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 305461)

  • 1. Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia.
    Lee SK; Oliver RT
    J Exp Med; 1978 Mar; 147(3):912-22. PubMed ID: 305461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells.
    Schöttker B; Schmidt-Wolf IG
    Ger Med Sci; 2011; 9():Doc18. PubMed ID: 21863132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
    J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis.
    Anderson JK; Moore JO; Metzgar RS
    Cancer Res; 1979 Dec; 39(12):4810-5. PubMed ID: 91428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed a greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocyte-derived dendritic cells from AML patients.
    Lee JJ; Choi BH; Kang HK; Kim SK; Nam JH; Yang DH; Kim YK; Kim HJ; Chung IJ
    Leuk Res; 2008 Nov; 32(11):1653-60. PubMed ID: 18501426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential.
    Liepert A; Grabrucker C; Kremser A; Dreyssig J; Ansprenger C; Freudenreich M; Kroell T; Reibke R; Tischer J; Schweiger C; Schmid C; Kolb HJ; Schmetzer H
    Cell Immunol; 2010; 265(1):23-30. PubMed ID: 20663492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elicitation of anti-leukemia cytotoxic responses.
    Bach FH; Sondel PM; Zarling JM
    Haematol Blood Transfus; 1979; 23():369-76. PubMed ID: 161756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
    Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.
    Voogt PJ; Falkenburg JH; Fibbe WE; Veenhof WF; Hamilton M; Van Krimpen BA; Bolhuis RL
    J Immunol; 1989 Mar; 142(5):1774-80. PubMed ID: 2521886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class I- like antigen expression on human leukemic cells.
    Peruccio D; Crepaldi T; Lovisone E; Paolino F; Foa R; Castagnoli C; Gabrielli A; Cappa PM; Richiardi P
    Tissue Antigens; 1987 Aug; 30(2):76-83. PubMed ID: 2890221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of staphylococcal protein A-treated human leukemic serum on autologous leukemic blast growth and mitogenesis of lymphocytes.
    Spitzer TR; Lazarus HM
    J Clin Immunol; 1984 Nov; 4(6):455-60. PubMed ID: 6392315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human acute myelogenous leukemia antigens defined by simian antisera: evidence for leukemia-associated antigens distinct from immune response-associated alloantigens.
    Mohanakumar T; Russell EC; Metzgar RS; Dunn N; Phibbs M; McWilliams NB; Maurer HM
    J Natl Cancer Inst; 1979 May; 62(5):1163-7. PubMed ID: 86633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immune responses between HLA-identical siblings: recognition of antigenic changes associated with acute myelogenous leukaemia.
    Zier KS; Huber C; Albert E; Braunsteiner H
    Clin Exp Immunol; 1980 Apr; 40(1):136-46. PubMed ID: 6446429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-restricted T cell alloresponses across HLA barriers: selection and identification of leukemia-restricted CTL in HLA-mismatched stimulator-responder pairs.
    Fujiwara H; Sconocchia G; Melenhorst J; Eniafe R; Nakamura R; Hensel N; Barrett AJ
    Bone Marrow Transplant; 2003 Aug; 32(4):371-8. PubMed ID: 12900773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous mixed lymphocyte culture reactions and generation of cytotoxic T cells.
    Vande Stouwe RA; Kunkel HG; Halper JP; Weksler ME
    J Exp Med; 1977 Dec; 146(6):1809-14. PubMed ID: 144772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells.
    van Luijn MM; van den Ancker W; Chamuleau ME; Zevenbergen A; Westers TM; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
    Cancer Res; 2011 Apr; 71(7):2507-17. PubMed ID: 21310823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte transformation induced by autologous cells. X. Soluble factors that generate cytotoxic T lymphocytes.
    Weksler ME; Moody CE; Ostry RF; Casazza BA
    J Exp Med; 1980 Aug; 152(2 Pt 2):284s-291s. PubMed ID: 6447745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic activity of lymphocyte subpopulations against autologous tumour cells in patients with myeloid leukaemias and preleukaemic disorders.
    Szabó B; Váczi L; Tóth FD; Kiss J; Kiss A; Rák K
    Acta Microbiol Hung; 1988; 35(1):25-33. PubMed ID: 3260709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of human leukemia to allogeneic and autologous lymphokine-activated killer cell activity: analysis of 252 samples.
    Teichmann JV; Ludwig WD; Thiel E
    Nat Immun; 1992; 11(3):117-32. PubMed ID: 1392400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helper and cytotoxic lymphocyte responses to chronic myeloid leukaemia: implications for adoptive immunotherapy with T cells.
    Lewalle P; Hensel N; Guimaraes A; Couriel D; Jiang Y Z; Mavroudis D; Barrett AJ
    Br J Haematol; 1996 Mar; 92(3):587-94. PubMed ID: 8616022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.